What White Coat Ceremonies Mean for Arizona’s Healthcare Future

Across Arizona, auditorium lights dim, applause swells, and hundreds of aspiring healthcare professionals step forward to mark their entry into patient care. Whether donning crisp white coats or receiving stethoscopes, these ceremonies represent one of medicine’s most poignant rites of passage—a dynamic transition from textbook study to clinical practice. In 2026, these milestones across the Grand Canyon State carry heightened significance, serving as both a personal achievement for students and a vital sign of hope for Arizona’s expanding medical and life sciences infrastructureContinue reading

BioLab Publishes Membrane Wrap Study for Pressure Ulcers

CND Life Sciences Announces Growth Financing Led by S-Curve Partners to Accelerate Expansion of the Syn-One Test® Platform and the Company’s Precision Neurology Mission

Scottsdale, AZ and Boca Raton, FL — August 4, 2026 — CND Life Sciences, a leading neurodiagnostics company advancing objective biomarker-based testing for neurodegenerative diseases, today announced the completion of growth financing led by S-Curve Partners, an operator-led healthcare investment firm focused on founder-inspired healthcare technology and diagnostics businesses. S-Curve was joined by current CND investors and shareholders, reflecting continued confidence in the Company’s commercial trajectory, expanding clinical adoption, and long-term strategic positioningContinue reading

Applications for the Flinn Bioscience Entrepreneurship Program Close Oct 30 2026

The 2027 cohort application is open. Apply by Friday, Oct. 30.

The Flinn Foundation Bioscience Entrepreneurship Program enables Arizona early-stage bioscience companies to access funding, professional support, connections, and networking opportunities. Since 2014, the Program has selected 66 companies in a competitive process to receive funding through a nonprofit partner. The 12 program cohorts have received more than $2.1 million in funding support. Continue reading